Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Sunny Linnebur

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Geriatric Nursing
4
2020
15
2.340
Why?
Geriatrics
4
2019
69
1.610
Why?
Health Services for the Aged
6
2018
70
1.240
Why?
Practice Guidelines as Topic
7
2020
1381
1.240
Why?
Polypharmacy
6
2023
74
0.980
Why?
Nursing Homes
7
2022
138
0.950
Why?
Anticoagulants
3
2018
547
0.900
Why?
Prescription Drugs
3
2012
116
0.790
Why?
Pharmacists
8
2021
231
0.780
Why?
Aged, 80 and over
27
2020
6306
0.770
Why?
Aging
4
2020
1611
0.750
Why?
Aged
38
2021
18969
0.740
Why?
Vitamin D Deficiency
4
2012
158
0.690
Why?
Vitamin D
5
2016
340
0.660
Why?
Bone Diseases
1
2020
57
0.650
Why?
Muscular Diseases
1
2020
104
0.650
Why?
Societies, Medical
2
2019
655
0.640
Why?
Hyponatremia
2
2016
37
0.630
Why?
Medication Therapy Management
3
2023
67
0.620
Why?
Vitamin K
1
2018
42
0.590
Why?
Automobile Driving
1
2019
129
0.580
Why?
Education, Pharmacy
4
2017
121
0.580
Why?
Warfarin
2
2009
136
0.580
Why?
Safety
1
2019
298
0.570
Why?
Interprofessional Relations
1
2019
246
0.560
Why?
Osteoporosis
2
2010
224
0.540
Why?
Self Report
2
2017
695
0.520
Why?
Chemical and Drug Induced Liver Injury
2
2010
125
0.520
Why?
Bupropion
1
2016
39
0.520
Why?
Humans
68
2023
114045
0.500
Why?
Curriculum
4
2019
813
0.490
Why?
Internet
1
2019
591
0.480
Why?
Health Literacy
1
2016
160
0.460
Why?
Health Status
1
2019
716
0.460
Why?
Health Personnel
2
2019
569
0.460
Why?
Antidepressive Agents
1
2016
195
0.460
Why?
Vitamins
3
2016
150
0.450
Why?
Drug Therapy
3
2017
74
0.450
Why?
Long-Term Care
3
2022
77
0.420
Why?
Delivery of Health Care
1
2020
828
0.420
Why?
Attitude of Health Personnel
1
2020
970
0.410
Why?
Cross Infection
2
2011
194
0.410
Why?
Urinary Retention
1
2012
19
0.400
Why?
Antihypertensive Agents
1
2015
428
0.400
Why?
Cholinergic Antagonists
1
2012
27
0.400
Why?
Physicians
2
2020
765
0.400
Why?
Prostatic Hyperplasia
1
2012
38
0.390
Why?
Product Surveillance, Postmarketing
1
2012
63
0.390
Why?
Pragmatic Clinical Trials as Topic
2
2022
47
0.390
Why?
Pharmacy Service, Hospital
2
2019
83
0.390
Why?
Drug Approval
1
2012
78
0.390
Why?
Health Communication
1
2012
40
0.380
Why?
Lower Urinary Tract Symptoms
1
2012
47
0.380
Why?
Students, Pharmacy
3
2017
97
0.370
Why?
Grifola
1
2009
1
0.340
Why?
Herb-Drug Interactions
1
2009
4
0.340
Why?
International Normalized Ratio
1
2009
42
0.340
Why?
Central Nervous System Agents
1
2009
5
0.340
Why?
Depression
3
2018
1133
0.340
Why?
Patient Education as Topic
3
2012
666
0.330
Why?
Blood Pressure
1
2015
1531
0.330
Why?
Pneumonia
2
2011
563
0.330
Why?
Renal Insufficiency
2
2016
137
0.330
Why?
Fractures, Bone
3
2016
367
0.320
Why?
Pain
4
2018
701
0.320
Why?
Central Nervous System Diseases
1
2009
60
0.320
Why?
Male
31
2020
55396
0.320
Why?
Drug Monitoring
1
2010
184
0.310
Why?
Educational Measurement
4
2017
235
0.300
Why?
Female
32
2020
59324
0.300
Why?
Hypertension
1
2015
1052
0.290
Why?
Drug Interactions
4
2018
337
0.290
Why?
Bone and Bones
1
2010
277
0.280
Why?
Faculty, Dental
1
2007
7
0.280
Why?
Dental Care for Chronically Ill
1
2007
11
0.280
Why?
Erectile Dysfunction
1
2006
38
0.270
Why?
Education, Dental
1
2007
24
0.270
Why?
Dietary Supplements
1
2010
459
0.270
Why?
Testis
1
2007
133
0.260
Why?
Urinary Tract Infections
2
2019
131
0.260
Why?
Cognitive Dysfunction
2
2021
282
0.260
Why?
Community Pharmacy Services
1
2005
42
0.240
Why?
Cholinesterase Inhibitors
1
2005
24
0.240
Why?
Patient Advocacy
1
2005
65
0.240
Why?
United States
8
2020
12137
0.240
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2016
296
0.240
Why?
Diphosphonates
1
2004
51
0.230
Why?
Nitrofurantoin
1
2004
7
0.230
Why?
Fluconazole
1
2004
16
0.230
Why?
Research Design
1
2009
919
0.220
Why?
Cholecalciferol
2
2016
47
0.220
Why?
Chronic Disease
4
2019
1577
0.220
Why?
Antifungal Agents
1
2004
128
0.210
Why?
Smoking Cessation
1
2006
374
0.210
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2007
373
0.210
Why?
Colorado
8
2018
4090
0.200
Why?
Age Factors
5
2015
2885
0.200
Why?
Anti-Bacterial Agents
1
2011
1471
0.200
Why?
Cyclohexanols
1
2002
9
0.200
Why?
Professional Role
4
2018
148
0.200
Why?
Research
1
2005
389
0.200
Why?
Vaginal Diseases
1
2002
17
0.200
Why?
Prevalence
4
2017
2247
0.200
Why?
Antidepressive Agents, Second-Generation
1
2002
38
0.200
Why?
Middle Aged
13
2020
26605
0.200
Why?
Nonprescription Drugs
2
2016
68
0.190
Why?
Administration, Oral
3
2018
725
0.190
Why?
United States Food and Drug Administration
2
2012
172
0.190
Why?
Ergocalciferols
2
2012
11
0.190
Why?
Medication Adherence
3
2017
531
0.180
Why?
Retrospective Studies
13
2021
12521
0.180
Why?
Self Care
2
2014
350
0.170
Why?
Alzheimer Disease
1
2005
442
0.170
Why?
Methenamine
1
2019
4
0.170
Why?
Diet
1
2007
1080
0.170
Why?
Anti-Infective Agents, Urinary
1
2019
13
0.170
Why?
Smoking
1
2006
1382
0.170
Why?
Patients
2
2011
163
0.160
Why?
Education, Continuing
1
2019
39
0.160
Why?
Sexism
1
2019
43
0.160
Why?
Physicians, Women
1
2019
55
0.160
Why?
Pharmacy
1
2019
28
0.160
Why?
Melatonin
1
2019
106
0.150
Why?
Recreation
1
2018
20
0.150
Why?
Transitional Care
1
2019
34
0.150
Why?
Patient Transfer
1
2020
142
0.150
Why?
Proton Pump Inhibitors
1
2019
94
0.150
Why?
Drug Therapy, Combination
2
2015
949
0.150
Why?
Drug Prescriptions
2
2010
237
0.150
Why?
Hemorrhage
1
2002
600
0.150
Why?
Independent Living
1
2018
84
0.150
Why?
Lung Diseases
1
2004
690
0.140
Why?
Medication Reconciliation
2
2019
25
0.140
Why?
Problem-Based Learning
2
2017
77
0.140
Why?
Education, Pharmacy, Graduate
1
2017
18
0.140
Why?
Guideline Adherence
2
2011
489
0.140
Why?
Cohort Studies
3
2015
4883
0.140
Why?
Schools, Pharmacy
1
2017
48
0.140
Why?
Health Education
2
2016
317
0.140
Why?
Patient-Centered Care
2
2023
470
0.130
Why?
Ambulatory Care Facilities
1
2018
212
0.130
Why?
Leadership
1
2019
291
0.130
Why?
Refuse Disposal
1
2016
2
0.130
Why?
Sleep Wake Disorders
1
2019
232
0.130
Why?
Ibuprofen
1
2016
75
0.130
Why?
Hypoglycemic Agents
2
2014
1011
0.130
Why?
Dementia
1
2018
186
0.130
Why?
Socioeconomic Factors
1
2020
1080
0.130
Why?
Marijuana Use
1
2018
167
0.130
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2015
38
0.120
Why?
Child Health
1
2016
126
0.120
Why?
Faculty, Medical
1
2017
226
0.120
Why?
Sodium
1
2016
184
0.120
Why?
Kansas
2
2011
29
0.120
Why?
Missouri
2
2011
61
0.120
Why?
Cognition Disorders
1
2018
476
0.120
Why?
Blood Glucose
2
2014
1827
0.120
Why?
Ambulatory Care
3
2008
479
0.120
Why?
Patient Care Team
2
2011
517
0.120
Why?
Creatinine
2
2007
424
0.110
Why?
Atrial Fibrillation
1
2018
325
0.110
Why?
Pharmaceutical Preparations
1
2016
164
0.110
Why?
Receptors, Adrenergic, alpha
1
2013
28
0.110
Why?
Priapism
1
2013
10
0.110
Why?
Adrenergic alpha-Antagonists
1
2013
29
0.110
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.110
Why?
Proline
1
2013
72
0.110
Why?
Nursing Staff
2
2010
38
0.110
Why?
Electronic Health Records
3
2014
799
0.100
Why?
Hoarding
1
2012
2
0.100
Why?
Respiratory Tract Infections
1
2016
319
0.100
Why?
Program Evaluation
1
2017
820
0.100
Why?
Accidental Falls
2
2016
151
0.100
Why?
Practice Patterns, Physicians'
2
2011
1175
0.100
Why?
Kidney
1
2019
1182
0.100
Why?
Teaching
1
2014
209
0.100
Why?
Assisted Living Facilities
2
2016
7
0.100
Why?
Prognosis
1
2019
3315
0.100
Why?
Education, Nursing, Continuing
1
2011
37
0.090
Why?
Adult
8
2020
30375
0.090
Why?
Interpersonal Relations
1
2014
338
0.090
Why?
Stakeholder Participation
2
2022
72
0.090
Why?
Administration, Inhalation
1
2012
637
0.090
Why?
Mass Screening
3
2018
979
0.090
Why?
Glucosamine
1
2010
12
0.090
Why?
Chondroitin Sulfates
1
2010
33
0.090
Why?
Diabetes Mellitus, Type 2
2
2014
2087
0.090
Why?
Parathyroid Hormone
2
2008
96
0.080
Why?
Anti-Anxiety Agents
1
2010
43
0.080
Why?
Piracetam
1
2009
15
0.080
Why?
Drug Administration Schedule
1
2011
714
0.080
Why?
Stroke
1
2018
1019
0.080
Why?
Blood Chemical Analysis
1
2010
90
0.080
Why?
Infection Control
1
2010
132
0.080
Why?
Delphi Technique
1
2009
157
0.080
Why?
Hip Fractures
1
2010
75
0.080
Why?
Immunization Programs
1
2010
204
0.080
Why?
Drug Dosage Calculations
1
2008
21
0.070
Why?
Conflict of Interest
1
2009
119
0.070
Why?
Surveys and Questionnaires
4
2018
4595
0.070
Why?
Anticonvulsants
1
2009
178
0.070
Why?
Evidence-Based Medicine
1
2011
662
0.070
Why?
Anxiety Disorders
1
2010
304
0.070
Why?
Decision Making
2
2011
760
0.070
Why?
Heptanoic Acids
1
2007
60
0.070
Why?
Comorbidity
1
2011
1447
0.070
Why?
Nutrition Policy
1
2007
54
0.070
Why?
Simvastatin
1
2007
58
0.070
Why?
Phosphorus
1
2007
81
0.070
Why?
Inpatients
1
2010
378
0.070
Why?
Orthodontics, Corrective
1
2006
7
0.070
Why?
Serum Albumin
1
2007
137
0.070
Why?
Premedication
1
2006
36
0.070
Why?
Cross-Sectional Studies
3
2017
4402
0.060
Why?
Isoxazoles
1
2006
51
0.060
Why?
Pyrroles
1
2007
181
0.060
Why?
Tobacco Products
1
2006
98
0.060
Why?
Nutritional Physiological Phenomena
1
2005
47
0.060
Why?
Life Expectancy
1
2005
46
0.060
Why?
Metabolic Clearance Rate
1
2004
102
0.060
Why?
Caregivers
1
2011
713
0.060
Why?
Outpatient Clinics, Hospital
1
2005
80
0.060
Why?
Medical Records Systems, Computerized
1
2005
88
0.060
Why?
Communication
3
2016
734
0.060
Why?
Influenza, Human
1
2010
543
0.060
Why?
Health Knowledge, Attitudes, Practice
2
2016
1168
0.060
Why?
Heart Failure
1
2017
1958
0.060
Why?
Pain, Postoperative
1
2006
190
0.060
Why?
Onychomycosis
1
2004
2
0.060
Why?
Bone Diseases, Metabolic
1
2004
53
0.060
Why?
Palliative Care
1
2010
641
0.060
Why?
Outpatients
1
2007
325
0.060
Why?
Risk Factors
2
2007
8614
0.060
Why?
Quality of Life
2
2023
2343
0.060
Why?
Patient Discharge
2
2020
770
0.050
Why?
Time Factors
2
2011
6077
0.050
Why?
Hematologic Diseases
1
2004
55
0.050
Why?
Rheumatic Diseases
1
2004
49
0.050
Why?
Algorithms
1
2010
1469
0.050
Why?
Data Collection
1
2005
618
0.050
Why?
Child
2
2023
18401
0.050
Why?
Sulfonamides
1
2006
444
0.050
Why?
Venlafaxine Hydrochloride
1
2002
11
0.050
Why?
Menstruation
1
2002
35
0.050
Why?
Health Care Costs
1
2005
381
0.050
Why?
Pharmaceutical Services
2
2016
76
0.050
Why?
Hospitalization
1
2010
1762
0.050
Why?
Potentially Inappropriate Medication List
1
2021
14
0.050
Why?
Liver Diseases
1
2004
254
0.050
Why?
Adolescent
4
2023
17800
0.050
Why?
Calcium
1
2007
1089
0.050
Why?
Nervous System Diseases
1
2004
254
0.050
Why?
Analgesics, Opioid
1
2008
771
0.040
Why?
Dose-Response Relationship, Drug
2
2016
1836
0.040
Why?
Biomarkers
1
2010
3397
0.040
Why?
Clinical Trials as Topic
1
2004
926
0.040
Why?
Kidney Function Tests
1
2019
140
0.040
Why?
Depressive Disorder
1
2002
330
0.040
Why?
Anxiety
2
2018
843
0.040
Why?
Protons
1
2019
73
0.040
Why?
Prospective Studies
2
2007
6195
0.040
Why?
Healthcare Financing
1
2018
6
0.040
Why?
Guidelines as Topic
2
2010
241
0.040
Why?
Double-Blind Method
2
2016
1656
0.040
Why?
Geriatric Assessment
1
2018
175
0.040
Why?
Nephrology Nursing
1
2016
5
0.030
Why?
Circadian Rhythm
1
2019
356
0.030
Why?
Glomerular Filtration Rate
1
2019
605
0.030
Why?
Clinical Protocols
1
2017
232
0.030
Why?
Pilot Projects
1
2020
1360
0.030
Why?
Education, Medical, Undergraduate
1
2017
160
0.030
Why?
Skilled Nursing Facilities
1
2016
121
0.030
Why?
Patient Readmission
1
2020
607
0.030
Why?
Obesity
1
2007
2505
0.030
Why?
Neuropsychological Tests
1
2018
926
0.030
Why?
Neoplasms
1
2008
2086
0.030
Why?
Sleep
1
2019
631
0.030
Why?
Cardiomyopathies
1
2017
298
0.030
Why?
Medicare
1
2018
661
0.030
Why?
Treatment Outcome
2
2019
9049
0.030
Why?
Cytochrome P-450 CYP3A
1
2013
61
0.030
Why?
Medical Audit
1
2013
75
0.030
Why?
Cardiovascular Diseases
1
2004
1726
0.030
Why?
Comprehension
1
2014
151
0.030
Why?
Diagnosis, Differential
1
2016
1331
0.030
Why?
Drug Evaluation
1
2012
77
0.020
Why?
Educational Status
1
2014
408
0.020
Why?
Drug Therapy, Computer-Assisted
1
2011
10
0.020
Why?
Electronic Mail
1
2011
54
0.020
Why?
Personal Autonomy
1
2011
39
0.020
Why?
Pharmacies
1
2011
32
0.020
Why?
Complementary Therapies
1
2011
74
0.020
Why?
Decision Trees
1
2010
82
0.020
Why?
Disclosure
1
2011
100
0.020
Why?
Midwestern United States
1
2010
38
0.020
Why?
Medical Informatics
1
2011
89
0.020
Why?
Follow-Up Studies
2
2009
4392
0.020
Why?
Clinical Competence
1
2016
882
0.020
Why?
Young Adult
2
2017
10444
0.020
Why?
Massage
1
2010
42
0.020
Why?
Child, Preschool
1
2023
9114
0.020
Why?
Emergency Service, Hospital
1
2020
1815
0.020
Why?
Hypoglycemia
1
2014
386
0.020
Why?
Medication Errors
1
2010
88
0.020
Why?
Epilepsies, Partial
1
2009
29
0.020
Why?
Primary Health Care
1
2018
1502
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2011
239
0.020
Why?
Self Administration
1
2008
122
0.020
Why?
Interviews as Topic
1
2010
575
0.020
Why?
Administration, Cutaneous
1
2008
117
0.020
Why?
Oxycodone
1
2008
44
0.020
Why?
Fentanyl
1
2008
67
0.020
Why?
Pain Management
1
2010
285
0.020
Why?
Delayed-Action Preparations
1
2008
158
0.020
Why?
Methadone
1
2008
77
0.020
Why?
Morphine
1
2008
121
0.020
Why?
Orthodontic Wires
1
2006
5
0.020
Why?
Kidney Diseases
1
2009
349
0.020
Why?
Statistics, Nonparametric
1
2006
384
0.020
Why?
Pain Measurement
1
2006
441
0.010
Why?
Randomized Controlled Trials as Topic
1
2008
1204
0.010
Why?
Sex Factors
1
2006
1706
0.010
Why?
Linnebur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)